•
Dec 31, 2023

CME Group Q4 2023 Earnings Report

CME Group reported strong Q4 2023 earnings, driven by record average daily volume and double-digit adjusted earnings growth.

Key Takeaways

CME Group reported a successful fourth quarter and full year of 2023, marked by record revenue and adjusted earnings. The company's Q4 performance was bolstered by a significant increase in interest rate volumes, particularly Treasury futures ADV. Average daily volume reached 25.5 million contracts in Q4, up 17% compared to the same period in 2022.

CME Group's average daily volume climbed to a record 24.4 million contracts in 2023.

Q4 average daily volume was 25.5 million contracts, up 17% versus fourth-quarter 2022.

Interest rate volumes increased by 36% in Q4, including a 46% rise in Treasury futures ADV.

The company delivered its tenth consecutive quarter of double-digit adjusted earnings growth.

Total Revenue
$1.44B
Previous year: $1.21B
+19.1%
EPS
$2.37
Previous year: $1.92
+23.4%
Average Daily Volume
25.51M
Previous year: 21.8M
+17.0%
Average Rate Per Contract
$0.682
Previous year: $0.651
+4.8%
Gross Profit
$1.23B
Previous year: $1.01B
+20.9%
Cash and Equivalents
$2.91B
Previous year: $2.72B
+7.1%
Free Cash Flow
$1.02B
Previous year: $957M
+6.9%
Total Assets
$130B
Previous year: $174B
-25.5%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group continues to focus on delivering new products and increased capital efficiencies, including their enhanced FICC cross-margining program.

Revenue & Expenses

Visualization of income flow from segment revenue to net income